Location out of bounds
Radial
Radial

Newsroom

Resources for journalists

All Publications
Test Tubes with Labels

Making blood health innovations possible

Milwaukee – September 17, 2018

In the world of research, federal grants and awards provide critical funding that enables investigative research. Prestigious, competitive and highly sought-after, the National Institutes of Health’s (NIH) grant program receives tens of thousands of applications each year; however, less than 20% of applicants are selected to receive funding. Since 1991, Versiti’s world-renowned Blood Research Institute (BRI) has been awarded millions of dollars of grants through the NIH, helping to propel exciting new research and discoveries in blood health innovations.

In the state of Wisconsin, the Blood Research Institute is one of the top three NIH grant recipients in the state. In 2017, it received 16 new grants from the NIH, and has received six so far in 2018. For example, in January, Blood Research Institute Vice President for Research Peter Newman, Ph.D., was awarded nearly $7 million from the NIH to study how proteins on the surface of platelets (which help blood to clot) become unintentional targets of the immune system, which can cause a severe bleeding disorder in fetuses and neonates. Thanks to the NIH grant, Dr. Newman will be able to research these proteins and lead the way for new diagnoses and personalized therapies for treating bleeding disorders.

Blood Research Institute investigators have also received the following NIH grants in 2018:

  • Lynn Malec, M.D.: $21,000 to study if an intravenous treatment for von Willebrand disease (the most common bleeding disorder) is more effective than standard treatments
  • Robert Montgomery, M.D.: $2,345,158 to better understand the genes that help blood to clot, and strategize new treatments for patients with hemophilia A
  • Karin Hoffmeister, M.D.: $4,866,000 to create the Translational GlycOmics Program to train new investigators and translate glycosciences into regular clinical practice
  • Gilbert White, M.D.: $1,419,932 to provide support for clinics to enroll participants from healthcare providers into the Precision Medicine Initiative Cohort Program
  • Sandra Haberichter, Ph.D.: $1,683,273 to study von Willebrand disease and how modifications to the von Willebrand factor may affect patient treatment


Grants from the NIH and other organizations are crucial to the life-saving research being done at the Blood Research Institute. It’s thanks to these funds that our investigators are able to discover treatments and cures to help patients in our communities, across the country and around the world. Learn more about how you can support this ground-breaking work.

Authors

Gilbert C. White, II, MD

Executive Vice President for Research
View Bio > Call: Fax: Email: gcwhite@bcw.edu
Gilbert C. White, II, MD

Robert Montgomery, MD

Senior Investigator
View Bio > Call: Fax: Email: bob.montgomery@bcw.edu
Robert R. Montgomery, MD

Sandra L Haberichter, PhD

Director, Hemostasis
View Bio > Call: Fax: Email:
Sandra L Haberichter, PhD

Lynn Malec, MD, MSc

Associate Medical Director, Hematology
Assistant Investigator
View Bio > Call: Fax: Email: Lynn.Malec@bcw.edu
Lynn Malec, MD, MSc

Other Publications

This particular image depicts platelets spreading on an artificial fibrinogen-coated surface, demonstrating what would happen if someone cut themselves.

Blood Research Institute investigator wins journal cover photo contest

April 8, 2019

Congratulations to Hervé Falet, PhD, and his winning photo “Platelet Fireworks,” which appeared on the cover of medical journal Platelets.

Read More
Hervé Falet, PhD working with an assistant in his lab

Filling in the gaps to better understand platelet production

April 8, 2019

Hervé Falet, PhD, is an expert in platelet function and is investigating how they form in the bone marrow.

Read More
John Pulikkan, PhD

What's in a gene?

March 19, 2019

Dr. Pulikkan would like to develop drugs that are specially targeted to the mutated leukemia cells, so that the drugs would have no side effects.

Read More
ic-arrow-right
x

This website uses cookies to ensure you get the best experience on our website. Learn more